Mybufen (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins. Lower prostaglandin levels diminish inflammation, pain signaling, and the hypothalamic response that raises body temperature.

The appropriate dose of Mybufen is determined by a qualified healthcare professional based on the individual’s age, weight, condition being treated, and any other medical considerations. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Ibuprofen is classified as pregnancy category B, indicating that it is generally considered safe in the first two trimesters when used as directed. However, it should be avoided in the third trimester. Breastfeeding mothers should consult a physician, as small amounts can pass into milk.

To place an order, submit an enquiry on the Mybufen product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Both ibuprofen (Mybufen) and naproxen belong to the NSAID class and share similar mechanisms of COX inhibition. Ibuprofen generally has a shorter half‑life, requiring more frequent dosing, while naproxen provides longer‑lasting relief but may have a higher risk of gastrointestinal irritation in some patients.

Mybufen should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mybufen is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort for some individuals.

Serious risks include gastrointestinal bleeding or ulceration, severe kidney injury, and rare but life‑threatening allergic reactions such as anaphylaxis. Patients with a history of ulcer disease, renal impairment, or cardiovascular disorders should use Mybufen only under medical supervision.

Mybufen should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those in the third trimester of pregnancy, patients with active gastrointestinal bleeding, severe renal or hepatic impairment, and anyone taking anticoagulants without physician guidance.